• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

XEN 45凝胶支架和Preserflo™微型分流器植入术后原发性滤过泡失败采用开放滤过泡修复术治疗的结果

Results of open bleb revision as management of primary bleb failure following XEN 45 gel stent and Preserflo™ Microshunt.

作者信息

Theilig Theresa, Papadimitriou Menelaos, Albaba Ghaith, Meller Daniel, Hasan Somar M

机构信息

Klinik für Augenheilkunde, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3249-3255. doi: 10.1007/s00417-023-06152-8. Epub 2023 Jul 6.

DOI:10.1007/s00417-023-06152-8
PMID:37410178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10587268/
Abstract

PURPOSE

The success of filtering surgery as in XEN-Gel-Stent (XEN) and Preserflo-Microshunt (PF) depends mainly on a functioning bleb. Primary bleb failure (PBF) is not uncommon and can be treated with needling or open bleb revision (OBR). The aim of the study is to compare surgical outcomes of OBR after XEN and PF.

METHODS

Eyes which received OBR as management of PBF following implantation of XEN or PF were retrospectively included. Intraocular pressure (IOP), number of IOP lowering medications (NoM), and success rates (SR) were compared between groups. Complete and qualified success were defined as IOP ≤18mmHg and a reduction of >20%, without and with medications, respectively.

RESULTS

29 eyes after XEN and 23 eyes after PF were included. Six months following OBR, IOP reduced from 24.2±4.7 to 13.5±4.6 after XEN and from 27.3±8.7 to 15.9±5.8mmHg after PF (both p<0.001). NoM did not change (0.7±1.3 to 0.4±0.8 after XEN and 1.2±1.3 to 1.0±1.5 after PF, p>0.05 for both). Complete SR were higher after XEN than after PF (58.6% vs. 30.4%, p=0.04). Complications were mild and managed mainly conservatively. Additional glaucoma surgery was needed in 17% and 30% of eyes after XEN and PF, respectively (p=0.26).

CONCLUSION

Although OBR was effective as management of PBF following XEN and PF, SR were higher after XEN than after PF along with comparable safety profile. The change of the surgical approach from ab interno during XEN-Implantation to ab externo during OBR seems to enhance SR compared to PF, where both interventions are done ab externo.

摘要

目的

XEN凝胶支架(XEN)和Preserflo微分流器(PF)等滤过性手术的成功主要取决于功能性滤过泡。原发性滤过泡失败(PBF)并不罕见,可通过针刺或开放性滤过泡修复术(OBR)进行治疗。本研究的目的是比较XEN和PF植入术后OBR的手术效果。

方法

回顾性纳入接受OBR治疗PBF的XEN或PF植入术后的眼。比较两组间的眼压(IOP)、降低IOP的药物数量(NoM)和成功率(SR)。完全成功和合格成功分别定义为IOP≤18mmHg且分别在不用药和用药情况下降低>20%。

结果

纳入XEN术后29只眼和PF术后23只眼。OBR后6个月,XEN术后IOP从24.2±4.7降至13.5±4.6,PF术后从27.3±8.7降至15.9±5.8mmHg(均p<0.001)。NoM未改变(XEN术后从0.7±1.3降至0.4±0.8,PF术后从1.2±1.3降至1.0±1.5,两者p>0.05)。XEN术后的完全成功率高于PF术后(58.6%对30.4%,p=0.04)。并发症较轻,主要采用保守治疗。XEN和PF术后分别有17%和30%的眼需要额外的青光眼手术(p=0.26)。

结论

尽管OBR作为治疗XEN和PF术后PBF有效,但XEN术后的成功率高于PF术后,且安全性相当。与PF相比,手术方式从XEN植入时的经内路变为OBR时的经外路似乎提高了成功率,PF的两种干预均为经外路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/3dafa917286a/417_2023_6152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/2c758d1ae66e/417_2023_6152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/2ad0210d67b4/417_2023_6152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/3dafa917286a/417_2023_6152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/2c758d1ae66e/417_2023_6152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/2ad0210d67b4/417_2023_6152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab64/10587268/3dafa917286a/417_2023_6152_Fig3_HTML.jpg

相似文献

1
Results of open bleb revision as management of primary bleb failure following XEN 45 gel stent and Preserflo™ Microshunt.XEN 45凝胶支架和Preserflo™微型分流器植入术后原发性滤过泡失败采用开放滤过泡修复术治疗的结果
Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3249-3255. doi: 10.1007/s00417-023-06152-8. Epub 2023 Jul 6.
2
XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results.XEN 凝胶支架与 PRESERFLO™ 微分流管植入治疗原发性开角型青光眼:两年结果。
Acta Ophthalmol. 2021 May;99(3):e433-e440. doi: 10.1111/aos.14602. Epub 2020 Sep 10.
3
A Comparative Analysis of Morphology and Dimensions of Functional Blebs following PRESERFLO-Microshunt and XEN-Gel-Stent, a Study Using Anterior Segment OCT.使用眼前节光学相干断层扫描对 PRESERFLO 微分流器和 XEN 凝胶支架术后功能性小泡的形态学和尺寸进行比较分析的研究
Diagnostics (Basel). 2023 Jul 9;13(14):2318. doi: 10.3390/diagnostics13142318.
4
Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.XEN 凝胶支架植入后针刺修复的疗效:一项前瞻性研究。
J Glaucoma. 2020 Jan;29(1):11-14. doi: 10.1097/IJG.0000000000001394.
5
Comparison of Safety and Efficacy Between Ab Interno and Ab Externo Approaches to XEN Gel Stent Placement.XEN凝胶支架植入的经内与经外途径的安全性和有效性比较。
Clin Ophthalmol. 2021 Jan 26;15:299-305. doi: 10.2147/OPTH.S292007. eCollection 2021.
6
Ab Interno XEN Gel Stent Implantation in Eyes with Previous Tube Shunt Surgery.在既往接受过引流管分流手术的眼中进行内路XEN凝胶支架植入术。
Clin Ophthalmol. 2022 Sep 30;16:3205-3212. doi: 10.2147/OPTH.S378038. eCollection 2022.
7
XEN-45 implantation for refractory uveitic glaucoma.XEN-45 植入术治疗难治性葡萄膜炎性青光眼。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):937-948. doi: 10.1007/s00417-023-06254-3. Epub 2023 Oct 19.
8
Two-year Outcomes of XEN Implantation with Minimal Bleb Needling.XEN植入联合最小化滤泡针刺的两年随访结果
J Curr Glaucoma Pract. 2022 May-Aug;16(2):79-83. doi: 10.5005/jp-journals-10078-1363.
9
Comparison of Clinical Outcomes Following Gel Stent Implantation via Ab-Externo and Ab-Interno Approaches in Patients with Refractory Glaucoma.难治性青光眼患者经外路和经内路植入凝胶支架后的临床结局比较
Clin Ophthalmol. 2022 Jul 6;16:2187-2197. doi: 10.2147/OPTH.S354038. eCollection 2022.
10
Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.原发性开角型青光眼和假性剥脱性青光眼微创 XEN 凝胶支架植入的两年疗效。
Acta Ophthalmol. 2021 Jun;99(4):369-375. doi: 10.1111/aos.14627. Epub 2020 Sep 30.

引用本文的文献

1
Management practices and surgical techniques for ab externo less invasive glaucoma surgery: a literature review and expert recommendations.外路微创青光眼手术的管理实践与手术技术:文献综述及专家建议
Graefes Arch Clin Exp Ophthalmol. 2025 May 8. doi: 10.1007/s00417-025-06843-4.
2
Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation.凝胶支架植入术后优化手术效果的外科技术最佳实践更新
Clin Ophthalmol. 2025 Jan 31;19:325-347. doi: 10.2147/OPTH.S487718. eCollection 2025.
3
Histopathological findings of failed blebs after microinvasive bleb surgery with the XEN Gel Stent and Preserflo MicroShunt.

本文引用的文献

1
Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy.比较经结膜微创青光眼手术与小梁切除术。
Acta Ophthalmol. 2022 Aug;100(5):e1120-e1126. doi: 10.1111/aos.15042. Epub 2021 Oct 9.
2
PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.PRESERFLO™微型分流器与小梁切除术:疗效和安全性的初步结果
Acta Ophthalmol. 2022 May;100(3):e779-e790. doi: 10.1111/aos.14968. Epub 2021 Jul 31.
3
Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study.
XEN 凝胶支架和 Preserflo 微分流管微创滤泡手术后失败滤泡的组织病理学发现。
Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2977-2984. doi: 10.1007/s00417-024-06479-w. Epub 2024 Apr 16.
PRESERFLO® MicroShunt 在原发性开角型青光眼的安全性和有效性:来自一项为期 2 年的多中心研究的结果。
Ophthalmol Glaucoma. 2022 Mar-Apr;5(2):195-209. doi: 10.1016/j.ogla.2021.07.008. Epub 2021 Jul 28.
4
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.外引流微管植入术与小梁切除术治疗原发性开角型青光眼:一项为期 2 年的随机、多中心研究的 1 年结果。
Ophthalmology. 2021 Dec;128(12):1710-1721. doi: 10.1016/j.ophtha.2021.05.023. Epub 2021 May 27.
5
Needling and open filtering bleb revision after XEN-45 implantation-a retrospective outcome comparison.XEN-45 植入术后针刺和开放滤过泡修复的回顾性结果比较。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2761-2770. doi: 10.1007/s00417-021-05204-1. Epub 2021 May 11.
6
Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study.小梁切除术与XEN凝胶微支架植入术治疗原发性开角型青光眼的疗效比较:一项回顾性单中心比较队列研究。
Sci Rep. 2020 Nov 9;10(1):19337. doi: 10.1038/s41598-020-76551-y.
7
Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study.单中心非随机研究中PRESERFLO微型分流器治疗原发性开角型青光眼患者的长期结果
J Glaucoma. 2021 Mar 1;30(3):281-286. doi: 10.1097/IJG.0000000000001734.
8
One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.难治性青光眼中独立 ab externo SIBS 微分流植入术的一年疗效。
Br J Ophthalmol. 2022 Jan;106(1):71-79. doi: 10.1136/bjophthalmol-2020-317299. Epub 2020 Oct 23.
9
Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.原发性开角型青光眼和假性剥脱性青光眼微创 XEN 凝胶支架植入的两年疗效。
Acta Ophthalmol. 2021 Jun;99(4):369-375. doi: 10.1111/aos.14627. Epub 2020 Sep 30.
10
XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results.XEN 凝胶支架与 PRESERFLO™ 微分流管植入治疗原发性开角型青光眼:两年结果。
Acta Ophthalmol. 2021 May;99(3):e433-e440. doi: 10.1111/aos.14602. Epub 2020 Sep 10.